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oeview questionEsF
The specific objectives are toW
ENF mrovide a narrative synthesis of all the interventionsI including a summary of the nature of the intervention using
the Template for intervention aescription and oeplication ETiaieoFI and assessment of study quality Erisk of biasFI
alongside the standardised intervention effect sizes. As a detailed synthesis already includes studies evaluating
interventions specifically targeting Mp fatigue ErefW Coa42MNSMPPTSPFI the narrative synthesis will focus on studies
evaluating interventions that EaF do not specifically target fatigueI or EbF measured fatigue as a secondary outcome.
E2F Conduct EpairJwiseF metaJanalyses to pool effect sizes across intervention types EexerciseI behaviouralI mixedF
and estimate statistical heterogeneity.
EPF airectly compare specific types of targeted versus nonJtargeted exerciseI behavioural and combined interventions
on fatigue in multiple sclerosisI using network metaJanalyses.
E4F Conduct exploratory moderator and sensitivity analyses to explore how treatment effects vary according to health
care professional EeCmF contactI type of MpI and study quality Ei.e. risk of biasF.
pearches
The following data sources will be searchedW Cumulative fndex to kursing and Allied eealth iiterature ECfkAeiFI
bxcerpta Medica aataBase EbMBApbFI msycfkclI MbaifkbI Allied and Complementary Medicine aatabase
EAMbaFI iatinJAmerican and Caribbean Centre on eealth pciences fnformation EiiiACpFI mhysiotherapy bvidence
aatabase EmeaooFI pmloTaiscusI teb of pcienceI and The Cochrane Central oegister of Controlled Trials
ECbkToAiF. oeference lists and citations of included studies and previous Mp fatigue reviews. Trial registersW
Cochrane iibraryI tel fCTomI kfeoI ClinicalTrials.govI ControlledJtrialsI aissertation Abstracts fnternational
torld CatI dreylit.orgI and lpen drey. fn additionI there will be contact with experts in the field. There will be no
language restrictions or date restrictions imposed. Additional information about the search strategy can be found in
the attached mac document.
Types of study to be included
oandomised controlled trials EoCTsF or controlled clinical trials ECCTsF of any behavioural andLor exercise
intervention for multiple sclerosis EMpF including parallel groupI crossover and cluster trials. A study will be labelled
CCT where the allocation mechanism is not truly random Ei.e. quasiJrandomisationF or is unclear in the manuscript.
Condition or domain being studied
Multiple sclerosis EMpF is a chronic inflammatoryI demyelinating and neurodegenerative disease of the central
nervous system ECkpF Ehingwell et al.I 2MNPF. catigue affects around 9M% of people with Mp EpwMpFI with over twoJ
thirds reporting it as their most troubling symptom EdiovannoniI 2MMSF. hingwellI b.I g. g. MarriottI et al. E2MNPF.
"fncidence and prevalence of multiple sclerosis in buropeW a systematic review." BMC keurology NPENFW N28.
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diovannoniI d. E2MMSF. "Multiple sclerosis related fatigue." gournal of keurologyI keurosurgery C msychiatry TTENFW
2JP.
marticipantsL population
Adults Eaged N8 and overF with a confirmed diagnosis of multiple sclerosis EMcaonald 2MMN; molman 2MMR;molmanI
2MNNF and all disease subgroups Erelapsing remittingI secondary progressive and primary progressive multiple
sclerosisF. ptudies that include people with Mp together with people with other medical conditions will be included if
data are reported separately. there data for participants with Mp are not reported but studies contain a heterogeneous
sample with at least RM% of participants with Mp we will contact the authors to try to obtain the results for the Mp
subgroup.
fnterventionEsFI exposureEsF
cor the narrative synthesisI study interventions must be defined as any behavioural or exercise intervention that does
not specifically target fatigueI but rather aims to improve other primary outcomesI such as moodI fitnessI strengthI
walking abilityI quality of life etc.I and examines fatigue severityLimpact as a secondary outcome. ptudies specifically
targeting fatigue from the previous review Eoef. Coa42MNSMPPTSPF will also be included alongside these studies in
the multiple treatment metaJanalysis. cor the purposes of this review a behavioural intervention is one that aims to
result in behaviouralI lifestyleI or attitudinal changes and may include changes in physical activity. Behavioural
interventions are broad rangingI typically incorporating selfJmanagement aspects and may include CBT for
depressionI relaxationI mindfulness trainingI educational strategiesI and multimodal approaches. An exercise
intervention is one that primarily aims to increase lifestyle physical activity or introduce structured exercise but may
also include components of behavioural interventions. mhysical activity is defined as any bodily movement produced
by skeletal muscles that requires energy expenditure and includes exercise as well as other activities which involve
bodily movement and are done as part of playingI workingI active transportationI house chores and recreational
activities EtelI httpWLLwww.who.intLtopicsLphysical_activityLenLF. bxercise is defined as a subcategory of physical
activity that is plannedI structuredI repetitiveI and purposeful in the sense that improvement or maintenance of one or
more components of physical fitness is the objective EtelI httpWLLwww.who.intLmediacentreLfactsheetsLfsP8RLenLF.
bxercise interventions are also varied and include structured exercise Esuch as aerobicI strength and conditioning
trainingFI balance interventionsI active gaming interventions Esuch as ubox hinectI kintendo tiiFI mindJbody Esuch
as yogaI Tai ChiLni dongFI danceI waterJbased Esuch as aquatic exerciseFI other lifestyle physical activityI
combinations of exercise as well as components of behavioural interventions.
ComparatorEsFL control
The comparator could include no interventionI usual careI standard medical careI placebo treatment or another active
intervention. cor the multiple treatment metaJanalysis treatment effects of intervention subtypes will be estimated
using treatment as usual as the reference comparator.
Context
fncluded interventions may vary in duration and take place in the hospitalI in the communityI at home or some
combination and could be selfJdirected or supervised or a combination. fnterventions may be delivered faceJtoJfaceI
or via the internetI pMAoT deviceI teleJ or videoJconferenceI in groups or oneJtoJone or in some combination.
fnterventions will be excluded if they do not measure fatigue severity andLor impact of fatigue as an outcome.
mharmacological and dietary studies will be excluded except where diet is included as part of a broader behavioural
approach.
lutcomeEsF
mrimary outcomes
The primary outcome of this review will be fatigue severity andLor impact of fatigue measured using a validated uniJ
or multiJdimensional selfJreport fatigue scale Esuch as the catigue peverity pcale Ehrupp et al.I N989FI the Modified
catigue fmpact pcale EmsAI N998FI the Chalder catigue pcale EChalder et al.I N99PFI the keurological catigue fndex
EMills et al.I 2MNMFI The molMfp short form ECook et al.I 2MN2FI the Checklist fndividual ptrength Esercoulen et al.I
N99SFI visual or numerical rating scales or an appropriate validated subscale of broader instruments Esuch as the
sitality subscale of the pcPS Etare and pherbourneI f992F.
catigue severity andLor impact of fatigue at the first postJintervention assessment pointI including postJintervention
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means and preJpost change scores between groups.
pecondary outcomes
Any broadly relevant physical or cognitiveLmental fatigability measures will be extracted. catigability has been
defined as “the magnitude or rate of change in a performance criterion relative to a reference value or given time of
task performance or measure of mechanical output” EhlugerI hruppI C bnokaI 2MNPI p.4NNF. Measures of
performance fatigue may be defined as decrements in performance in voluntary activationI strengthI power and
endurance during sustained tasks. The cognitive domain of fatigability has been measured as “declines in either
reaction time of accuracy over time on continuous performance tasksI or a probe task given before and immediately
after a fatiguing cognitive task” EhlugerI hruppI C bnokaI 2MNPI p.4N4F. fn additionI selfJreported fatigue severity
andLor impact of fatigue Eas measured aboveF at followJup. hlugerI B. M.I i. B. hruppI et al. E2MNPF. "catigue and
fatigability in neurologic illnesses proposal for a unified taxonomy." keurology 8ME4FW 4M9J4NS.
Cognitive or physical fatigability measured at postJtreatment. catigue severity andLor impact of fatigue measured at
PJS and >S months followJup.
aata extractionI Eselection and codingF
All titles and abstracts will be reviewed by two independent reviewers. The full paper review will be conducted by
two independent reviewers. All discrepancies related to eligibility will be discussed between the two reviewers and
other team members will be consulted if a consensus cannot be reached.
To ensure accuracy of data extraction across reviewersI an initial random sample of 2M% of studies will be extracted
by four independent reviewers using a data extraction tool developed a priori based on the Cochrane eandbook
recommendations and a truncated version of the Tfaieo duidance Eeoffmann et al 2MN4F.
As part of this processI interJrater agreement for risk of bias EooBF Esee section 2TF will be checked using CohenDs
kappa coefficient statistic ECohenI N9SMF. ppecificallyI a first round of NM% of doubleJextracted ooB information will
be checked for consistency. This will be followed by training to resolve any discrepancies and then a second round of
double extraction of the same studies. A third round of double extraction will be conducted on the next NM% of
studies. ff there is ‘good’ consistency across the second and third rounds Ei.e. 2M%F EAltmanI N99NFI all remaining
studies will be singleJextractedI with metaJanalytic data crossJchecked by another reviewer. 
aata to be extracted will includeW ptudy faI dateI country and clinical settingI study designI rationale of studyI
eligibility criteriaI participant characteristics Ee.g. ageI genderI years since diagnosisI type of MpI degree of
disabilityFI flowchart of participants through all stages of studyI description of interventionI basic intervention costs if
availableI description of comparison groupEsF andI if appropriateI description of the durationI frequencyI how
deliveredI who deliveredI format of deliveryI training of person deliveringI whether adapted for MpI and whether
concomitant interventions were givenW Comparability of baseline characteristics between treatment and control arms
Enumber enrolled in trial and each groupI presence of sample size calculationI numbers included at each followJup
and reasons for dropout and withdrawalI attempts at maskingI description of randomisationI allocation concealment
and description of followJupF. lutcome measuresI timing of outcome administrationLmeasurementI whether intentionJ
toJtreat EfTTF analysis was undertakenI secondary outcomes includedI such as quality of life and mood and whether
positive effects were reported for the secondary outcomesI for nominal outcomes Edenominator and numerator in each
category for each groupFI for interval and ordinal data EkI meanI pa for each groupF or EkI medianI fno or rangeF as
appropriate. fntervention descriptions will be based on relevant elements within Tfaieo duidance Eeoffmann et al.I
2MN4F. Altman ad EN99NF mractical statistics for medical research. iondonW Chapman and eall. CohenI gacob EN9SMF.
A coefficient of agreement for nominal scales. bducational and msychological Measurement. 2M ENFW PT–4S.
eoffmannI T. C. and M. c. talker E2MNRF. "TfaieoJing up’ the reporting of interventions in stroke researchW the
importance of knowing what is in the ‘black box." fnternational gournal of ptroke NMERFW SRTJSR8.
oisk of bias EqualityF assessment
ooB assessment will be conducted according to the Cochrane eandbook for pystematic oeviews of oisk of Bias tool
Eeiggins 2MNNFI includingW random sequence generationI allocation concealmentI blinding EparticipantsI personnel and
outcome assessorsFI incomplete outcome dataI selective outcome reporting and other potential sources of bias.
eiggins gmI Altman adI dotzsche mCI guni mI Moher aI lxman AaI pavovic gI pchulz hcI teeks iI pterne gAI
Cochrane Bias Methods droup; Cochrane ptatistical Methods droupW The Cochrane Collaboration’s tool for assessing
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risk of bias in randomised trials. BMg. 2MNNI P4PW dR928JNM.NNPSLbmj.dR928.
ptrategy for data synthesis
mlanned quantitative analyses. there data are available from more than one study of a particular intervention type we
will pool treatment effects estimates. ppecificallyI in three pairJwise random effects metaJanalyses separately for
behaviouralI exercise and combined interventions respectivelyI versus any comparatorI to determine overall effects.
The decision to pool data will be based on the number of studies and the detailed intervention descriptions indicating
sufficient methodological homogeneity within intervention types. there insufficient data are available or where
clinical and methodological heterogeneity means that it is not possible to pool results in metaJanalysis we will present
individual study estimates of effect and conduct a narrative synthesis Emopay et al.I 2MMSF. 
there there are multiple intervention groups within a trialI we will combine all relevant data from multiple
intervention or multiple control groups into a single intervention or control group to avoid multiple counting of
participant data. fn studies where the effects of clustering have not been taken into accountI and where intra cluster
correlation EfCCF coefficients have been reportedI we will adjust the standard deviations for the design effect to avoid
unit of analysis errors. fn the case of crossover trialsI we will assess the risk of bias associated with the suitability of
the design and the potential for a carryover effect following behavioural or exercise interventions. there bias is
judged to be minimal analysis of data will be conducted using a paired analysis EblbourneI 2MM2F where possible or
where this information is not availableI only data up to the point of first crossover will be used for analysis.
eeterogeneity will be classified using the thresholds given in the Cochrane handbook
httpWLLhandbook.cochrane.orgLchapter_9L9_R_2_identifying_and_measuring_heterogeneity.htm. Analyses will
examine sources of heterogeneity. te will conduct sensitivity analyses based on study quality. te will use stratified
metaJanalyses to explore heterogeneity in effect estimates according toW study quality; study populations; the logistics
of intervention provision; and intervention content. te will also assess evidence of publication bias. blbourneI a. o.I
AltmanI a. d.I eigginsI g. m.I CurtinI c.I torthingtonI e. s.I C sailI A. E2MM2F. MetaJanalyses involving crossJover
trialsW methodological issues. fnternational journal of epidemiologyI PNENFI N4MJN49. mopayI g.I e. oobertsI et al.
E2MMSF. duidance on the conduct of narrative synthesis in systematic reviews a product from the bpoC methods
programme version N. bpoC methods programme xlnline] Available rpdated 2MMS
Analysis of subgroups or subsets
The main analysis will be based on three pairwise metaJanalyses of the total treatment effect for all the behaviouralI
exerciseI and mixed studies. mlanned subJgroup analyses based on grouping subJtypes within these main types Ee.g.
MindfulnessI CBT for depressionI combined; aerobic enduranceI resistanceI balanceI flexibility and combinationF
with any type of comparator group Ei.e. active or inactive controlsF. aue to known methodological heterogeneity in
control comparators from a previous review of fatigue targeted interventionsI a multiple treatment metaJanalysis will
estimate the treatment effect of intervention subtypes against a common comparator Etreatment as usualF
incorporating both nonJtargeted and targeted fatigue interventions. This analysis will incorporate data from targeted
fatigue interventions extracted in a separate review ECoa42MNSMPPTSPF. The method for computing the pooled
treatment effect estimates will use a multivariate metaJanalysis framework implemented in ptata using maximum
likelihood methods. sariables potentially explaining betweenJstudy heterogeneity will be included as covariates Ee.g.
Mp typeI risk of biasI publication yearI targeted vs nonJtargetedF. fn addition to pooled treatment effectsI the estimates
from the multivariate metaJanalysis will be used to estimate the rank ordering treatment subtypes by efficacy using
estimates of their ranking probabilities Ei.e. surface under the cumulative ranking curve prCoAF. Consistency in the
direct and indirect effects will be considered and the models results presented only where this is there is no indication
of biased estimates.
there possible exploratory moderator and sensitivity analyses will include health care professional contact EeCmF
compared to no or limited eCm contact Ee.g. session dosageFI type of Mp ErelapsingJremitting versus more
progressive forms of MpFI studies comparing interventions to active placebo comparators and treatment as usual Ee.g.
exercise vs noJexercise controlFI and low or high study quality based on the ooB assessment.
aissemination plans
The findings will initially be presented to the Mp pociety rh Clinical Trial ketwork ECTkF catigue working group
Ewhich includes service usersF. This will be followed by a stakeholder event. The purpose of this event is to present
the findings from the review to people with Mp EpwMpF and health care providers. cinallyI a condensed version of
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the final report will be submitted for publication in a peerJreviewed scientific journal. The data will also be presented
at relevant conferences.
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